drugset / Trial / NCT02186665

Plaque Psoriasis Study in Pediatric Subjects

NCT02186665

Phase 4 Completed 19 enrolled Galderma R&D
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the safety, efficacy and calcium metabolism of up to 8 weeks of treatment with calcitriol 3 mcg/g ointment versus its vehicle, when used twice daily, without occlusion, to treat children aged 2 to 12 years, with plaque psoriasis.

Timeline

Start
2014-07
Primary completion
2015-11
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcitriol Small molecule 3 unknown Topical

Indications